← Back to Clinical Trials
Recruiting NCT06993454

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Trial Parameters

Condition Type 2 Diabetes
Sponsor AdventHealth Translational Research Institute
Study Type INTERVENTIONAL
Phase N/A
Enrollment 12
Sex ALL
Min Age 25 Years
Max Age 55 Years
Start Date 2025-04-25
Completion 2026-03
Interventions
Magnetic Resonance Liver AssessmentBike Exercise VO2maxDEXA

Brief Summary

The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).

Eligibility Criteria

Inclusion criteria for individuals with T2D and elevated liver fat ≥5.6% 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or (pre-menopausal) female, aged 25-55 years 4. Body mass index (BMI) between 25 and 45 kg/m2 5. Sedentary (1 day or less per week of structured exercise) 6. Type 2 diabetes mellitus: HbA1c ≥7.5% 7. Liver fat ≥5.6% based on MRI 8. Weight stable (± 2 kg) for prior 3 months Inclusion criteria for lean, healthy controls 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or (pre-menopausal) female, aged 25-55 years 4. Body mass index (BMI) between 18.5 and 27.5 kg/m2 5. Normal liver fat (FibroScan CAP \<249dB/m, \<5.6% liver fat based on MRI) 6. Weight stable (± 2 kg) for prior 3 months 7. Active (≥3 day/week of structured exercise) Exclu

Related Trials